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Aim: To report the outcome of patients treated for colonic neoplasms using a laparoscopic assisted
technique since its introduction at the University Hospital of the West Indies, Jamaica.
Subjects and Methods: All consecutive patients undergoing laparoscopic assisted colectomy were entered
into a prospective database and this data analysed. Data collected included patient demographics, pre-
operative diagnosis, operative events, post-operative morbidity and outcome.
Results: Over the thirty-six months period July 1, 2005eDecember 31, 2005 and July 1, 2006eDecember
31, 2008, thirty patients each underwent laparoscopic assisted colectomy for a colonic neoplasm. Their
mean age was 63 years with M: F ratio of 1:2. Seventy-four per cent of the patients had carcinomas
which was located on the right and sigmoid colon in 17 and 10 patients respectively. Mean operative
time was 98 min for patients with right-sided lesions and blood loss for the entire group was minimal.
Two patients were converted to open resections. Median duration of hospitalization was ﬁve days. There
was no mortality but three patients had complications. After median follow-up of 30 months, there was
no local or systemic recurrence.
Conclusions: Appropriately selected patients with colonic neoplasms can be safely subjected to a lapa-
roscopic assisted resection and expect to enjoy the advantages of this technique even in a developing
country setting.
The outcome of thirty consecutive laparoscopic assisted colectomies is reported demonstrating that this
technique can be safely applied to selected patients with colonic carcinomas in developing countries.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The success with laparoscopic cholecystectomy sparked a revo-
lution inminimal access surgery, with the extension of laparoscopic
techniques to other general surgical procedures. Laparoscopic
colectomy was ﬁrst introduced for diverticular disease but was
soon extended to involve malignant disease. Since then there have
been several studies proving the safety of laparoscopic colonic
resections for malignant colonic neoplasms, with signiﬁcant
advantages being demonstrated when compared to conventional
laparotomy. It is now well established in the developed world, with
considerable interest growing in developing countries, albeit with
caution.1 Laparoscopic colectomy was ﬁrst introduced at the
University Hospital of the West Indies (UHWI) in 2005. This report
describes our experience with this procedure since its addition to
the surgical armamentarium at the UHWI.. Plummer).
ciates Ltd. Published by Elsevier Lt2. Subjects and methods
This report comprises thirty consecutive patients who under-
went laparoscopic assisted colectomy for colonic neoplasms at the
UHWI during a thirty-six month period 2005e2008. These patients
were selected from the overall group referred to the general surgical
team for colonic resections. All patients had pre-operative colono-
scopy with conﬁrmation, by biopsy, of carcinoma or of an advanced
adenoma which was not resectable by colonoscopic techniques.
Patients with palpable masses were excluded. All patients had no
evidence of metastatic disease on pre-operative ultrasound or
contrast computer tomography scans of the abdomen.
Theywere all performed under general anaesthesiawith routine
uretheral catheterization. Patients were divided into two main
groups and this determined the standard operative technique. For
patients undergoing laparoscopic assisted right hemicolectomy,
pneumoperitoneum was created through a 12 mm visual port
placed at the umbilicus using the open Hassan technique. Under
laparoscopic vision, two 5mmworking ports were placed along the
mid-clavicular line in the left upper and lower quadrants. Thesed. All rights reserved.
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and hepatic ﬂexure. Both the surgeon and assistant surgeon were
placed on the patient’s left and the video monitor placed on the
patient’s right. After a general exploration, the patient was placed
in the Trendelenburg position where the caecum, appendix and
right colon, including hepatic ﬂexure, were mobilized commencing
laterally. Once the colon was adequately mobilized, the umbilical
incision was extended to 4e6 cm, allowing for colonic exterior-
ization, division of its mesentery, resection and anastomosis
(sutured or stapled depending on availability). The remaining colon
was returned to the peritoneal cavity. The umbilical fascia was then
closed with 0-polypropylene sutures and the skin sutured. The
5 mm ports were closed with steri-strips only.
Patients undergoing left hemicolectomy or sigmoid colectomy
were placed in the lithotomy and Trendelenburg positions. Has-
son’s technique was used to create a pneumoperitoneum through
an umbilical incision. A 12 mm port was introduced into the right
lower quadrant to accommodate a linear stapler and two 5 mm
ports were placed- one on the right, in line with the umbilicus and
the other in the left lower quadrant. The procedure was routinely
commenced with dissection and division of the rectosigmoid
junction using a linear cutter/stapler. The sigmoid and descending
colon was mobilized, commencing medially with dissection and
division of the inferior mesenteric artery using the Haemolock
clips or the Ligasure. The left ureter was routinely identiﬁed prior
to this division. Mobilization of the descending colon and splenic
ﬂexurewere completed using electrocautery or a Harmonic Scalpel.
After adequate mobilization of the colon and extension of the
umbilical port for 3e4 cm, the colonwas exteriorized, resected, the
anvil of a circular stapler introduced, secured and the proximal
bowel returned to the peritoneal cavity. The umbilical incision was
closed, the pnuemoperitoneum re-created and the camera re-
introduced through the 12 mm right lower quadrant port. Gastro-
intestinal continuity was then re-established using a circular
stapler trans-anally. A wound protector at the extraction site (the
umbilical port) was not used.
Patients were offered oral ﬂuids on the ﬁrst post-operative day
and were graduated to a diet once they were passing ﬂatus or had
a bowel action. The urethral catheter was removed on the second
post-operative day, while parenteral analgesics were discontinued
once the patients tolerated diet. They were discharged home after
tolerating diet for approximately 12 h.
In this study, all consecutive patients who underwent laparo-
scopic assisted colonic resections for neoplastic disease were
identiﬁed. Data were prospectively collected from these patients
over a thirty-six month period July 1, 2005 to December 31, 2005
and July 1, 2006 to December 31, 2008. The data collected included
patient demographics, pre-operative diagnosis, operative details,
post-operative morbidity andmortality. The datawere entered into
a Microsoft Excel worksheet and analyzed using the Statistical
Package for the Social Sciences (SPSS version 14).
3. Results
Over the study period, 35 patients had laparoscopic assisted
colonic resection at the UHWI. These included four who underwent
surgery for diverticular disease (three sigmoid colectomies and one
subtotal colectomy) and one patient who underwent rectosigmoid
resection for endometriosis. These ﬁve patients were excluded
leaving 30 patients who had a pre-operative diagnosis of
a neoplasm and formed the basis of this analysis.
The mean age of the patients was 63 years (range 45e84 years)
with a male: female ratio of 1:2. Seventeen patients had right
hemicolectomy, ten had sigmoid colectomy and two had left
hemicolectomy. One patient underwent laparoscopic assistedsubtotal colectomy for a descending colon carcinoma and
a synchronous, large adenoma at the hepatic ﬂexure. Two patients
were converted to open surgery; one due to equipment failure
(patient with an ascending colon lesion) and the other due to
extensive pelvic adhesions post hysterectomy, with inability to
identify the colonic lesion. In the latter patient, the lesion was not
appreciated after full mobilization of the sigmoid. The decision was
made to convert because intra-operative colonoscopy was not
available. The lesion was eventually located in the region of the
splenic ﬂexure. Mean operative time for the entire group was
150 min but for right hemicolectomies, it was 98 min. Mean oper-
ative blood loss for the group was 185 mls and median duration of
hospitalizationwas ﬁve days (range 3e23 days). Three patients had
combined procedures; two laparoscopic cholecystectomies and one
bilateral inguinal hernia repair. There were no deaths, anastomotic
complications or wound infections. Three post-operative compli-
cations were noted in this series. One patient required re-explora-
tion on day 14 post-operation for intestinal obstruction. Dilated
bowel was found without an obstructing point and she required
a further nine days in hospital before she was re-established on
a diet. Another patient needed drainage of a pelvic collection 30
days after laparoscopic assisted right hemicolectomy while a third
patient was found to have an incisional hernia about 12 months
after sigmoid resection. This required operative mesh repair.
The commonest indication for laparoscopic assisted colectomy
was colorectal carcinoma. The ﬁnal histologic diagnosis of the
resected specimens revealed Dukes A, B and C carcinoma in 20%,
27%, and 27% respectively. Adenomas accounted for 26% of cases.
Median follow-up for the group was 30 months (range 9e40
months). During this period there were two deaths, one patient at
12 months from an unrelated cause and another within ten
weeks of surgery from overwhelming sepsis related to chemo-
therapy. All other patients were well without evidence of
recurrent disease, including port-site metastasis, at their last
follow-up visit.
4. Discussion
Laparoscopic surgery for colorectal neoplasia was ﬁrst reported
as a case report after successful resection of a villous adenoma in
1991.2 Subsequently, more case reports of the successful use of
laparoscopy in colonic resection were published, including cases of
laparoscopy in colon cancer patients.3 There were initial concerns
about oncologic safety, including the increased risk of recurrence by
the way of port-site metastasis.4 However, laparoscopic colonic
resection for curable cancer is now being performed worldwide. It
is now ﬁrmly established as a viable, and perhaps, the preferred
option for colon cancer resection.5
The beneﬁts of laparoscopic surgery are well established and
result from the reduced surgical trauma through the use of smaller
incisions plus minimal bowel handling which leads to a reduction
in the systemic inﬂammatory response.6,7 The reduced disturbance
of the immune function has led to the suggestion that a laparo-
scopic approach may have an added beneﬁt in cancer patients in
reducing tumour recurrence and improving survival.8 More
acceptable however, is that there is improved pulmonary function,
earlier return of bowel function, less post-operative pain, faster
return to activity and ultimately, shorter hospital stay. Compared to
conventional open surgery, cosmetic results are excellent. This is
supported by several large multicentre randomized controlled
trials and meta-analyses conﬁrming the beneﬁts and allaying the
oncologic safety concerns of laparoscopic colorectal cancer resec-
tion. These include the Barcelona trial,9 the Clinical Outcomes of
Surgical Therapy (COST) Study Group trial,10 the Colon Cancer
Laparoscopic or Open Resection (COLOR) Study Group trial11 and
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with Colorectal Cancer (MRC CLASICC) trial.12 These have shown
superior short term outcome in favour of laparoscopic surgery with
respect to post-operative pain, return of bowel function, length of
hospitalization and cosmesis. Operative time for our series is
similar to the results of the COST trial and could have been
marginally reduced considering that three patients had additional
surgical procedures. Similarly, the median length of hospitalization
of ﬁve days, in our series, is similar to some published reports
which are approximately a day earlier than for open colectomies. It
is also expected that this should be further reduced with a protocol
of fast-track surgery which was not practised with this group. Our
conversion rate is alsowell within the 20%which is often quoted for
colonic resection. We realize that the group was selected, which is
biased towards this more favourable outcome.
The superiority of laparoscopic assisted resections is somewhat
short-lived and after four weeks there is no signiﬁcant difference in
quality of life in patients subjected to laparoscopic colectomy
compared to conventional colectomy.13,14 Importantly, yet to be
documented, are additional potential long term beneﬁts such as
a reduction in incisional hernia formation and episodes of intestinal
obstruction due to adhesion formation. These are important
beneﬁts and translate to important reduction in overall cost of
surgery to the society.
Before laparoscopic colon resection for cancer could be consid-
ered a replacement for open colectomy as standard of care, onco-
logic safety had to be demonstrated with at least equivalent
recurrence and survival rates for laparoscopic surgery. This
evidence is available through the COST trial which reported results
after a median of 4.4 years of follow-up showing local recurrence
(16% lap. Vs 18% open) and overall survival at 3 years was similar
between groups (86% lap. Vs 85% open). Two meta-analyses have
also been published providing further supportive evidence. Data
from four databases (Barcelona, COST, COLOR and CLASICC trials)
were used to develop a meta-analysis of 1765 patients from a total
of 92 centres. There was no statistically signiﬁcant difference in
disease-free and overall survival in either group. After 3 years,
disease-free survival was calculated to be 75.8% for the laparoscopic
group and 75.3% for the open group. Overall survival was 82.2% and
83.5% respectively. The follow-up period was admittedly shorter
than desired. However, 80% of recurrences occur within 3 years and
thus these ﬁndings should be representative.5 Jackson15 examined
10 randomized controlled trials with a total of 3830 patients.
Follow-up in all cases was over 18 months and similar results were
observed. Although the follow-up for our series is relatively short,
we are encouraged by the ﬁndings of no local, port-site or systemic
recurrence after a median 30 months of follow-up. We realize that
a quarter of the patients had benign neoplasms, but this is the
group that should be operated on by the surgical team in the earlier
stages of their learning curve. This is also our main reason for
selecting clinically non-palpable tumours which are less likely to be
locally advanced. This accounted for approximately 75% of the
group. The application of laparoscopic resection to patients with
rectal cancer should also now be considered as there is good
evidence that these patients can have similar long term survival
and quality of life compared to open resections.16
One of the limiting factors to the widespread use of laparoscopy
in colorectal cancer treatment has been the steep learning curve
and degree of expertise required. Smith,17 after assessing laparo-
scopic left and right hemicolectomies, concluded that a minimum
of 25 hand-assisted and 50 totally laparoscopic colectomies should
be performed before the surgeon is considered competent. The
hand-assisted laparoscopic colectomy, thought to be an alternative
to a standard laparoscopic resection for surgeons in the earlier part
of their learning curve, was not employed at our institution.While not represented in our series, the laparoscopic technique
can be utilized for palliation including stoma creation and staging
purposes.4 The concern of oncologic safety is moot in patients with
metastatic colorectal cancer. It seems evident that laparoscopy
would be beneﬁcial in these patients as all the beneﬁts prevail
while the potential concerns do not. No randomized trials have
addressed this issue to date but several case series have been
reported that have demonstrated its advantage.17e19
Laparoscopy may also provide savings, as patients have faster
recovery and are hospitalized for a shorter period of time. However,
these are potentially absorbed by the longer operative times,
increased cost of specialized equipment and operating theatre
consumables. Conversion to an open technique adds to the cost.
Franks et al20 evaluated 682 randomized patients, a subset of the
CLASICC trial for overall cost. Operative costs were found to be
signiﬁcantly greater in the laparoscopic group. This may be an
initial deterrent in our population, but as we have already repor-
ted,21 it must be embraced with innovation, in partnership with
manufacturers of laparoscopic equipment, if we are to offer modern
surgical care for some disease and to retain our position as the
leader in post-graduate surgical training in this region.
5. Conclusion
In a developing country setting, laparoscopic colectomy can be
safely performed. A dedicated team can achieve sufﬁcient numbers
to overcome the ‘learning curve’ and will allow our patients to
enjoy the proven beneﬁts of a laparoscopic resection. Once patients
are appropriately selected, it should be a valid surgical option for
both curative and palliative means in the care of patients with
colonic neoplasms.
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